A recent publication in the Journal of the American Medical Association (JAMA) Network Open evaluated the accessibility of coronavirus disease 2019 (COVID-19) “Test to treat” sites across age, rurality, race, and ethnicity.
The “Test to Treat” initiative announced in March 2022 in the United States (United States) to help others access COVID-19 treatments. People can get tested for COVID-19, contact a health care provider, get prescriptions for oral antiviral treatment, and have the prescription filled in one place. However, there are fears that minority and high-risk populations may not be able to access this program.
In the existing study, researchers assessed geographic disparities in access to testing sites to treat COVID-19 for population subsets across age, rurality, ethnicity, and race. The researchers analyzed the geographic locations of all the test sites to treat and estimated population times. Medium to the ten closest sites to calculate the shortest time.
They then calculated the national proportion of demographic subgroups within X min of the nearest location by weighting all census tracts according to population size, stratification across population demographics at the census tract level, and aggregating driving times across demographic subgroup. Median driving times across the subgroup were calculated with 95% confidence periods (CIs).
Researchers have known more than 2220 exclusive testing sites to treat COVID-19 spread near metropolitan centers. The shortest times were mainly in urban areas. 15% of the general U. S. population is in the U. S. 59% of the U. S. rural population is in the U. S. He lived more than an hour from the nearest location.
Overall, 17 percent of seniors, 30 percent of Native Americans or Alaska Natives, 8 percent of Hispanics, 8 percent of blacks and 17 percent of whites were within an hour of the nearest location. ) lived farther from Test to Treat sites than white Americans (13. 9 min).
In contrast, Hispanics (9. 2 min), blacks (10 min) and Asians (8 min) lived closer to Test to Treat sites than whites. (11 min), which remained constant across all demographic subgroups. In particular, Alaska Natives or American Indians had the longest times in rural (74. 9 minutes) and urban (13. 8 minutes) subpopulations.
In summary, the study found that 15 percent of the U. S. population is in the U. S. population. In the U. S. , 59% of the rural population and 30% of American Indians or Alaska Indians lived more than 60 minutes from the nearest COVID-19 testing site. Rural citizens had 58 minutes more to the nearest location than urban citizens.
Although other Asian, Hispanic, and black people lived near testing sites to treat, geographic accessibility alone would not reflect pharmacoequity. Therefore, equitable distribution schemes make some representation of protective net hospitals, local pharmacies and fitness centers in the Test to Treat program.
Written by
Tarun was founded in Hyderabad, India. He holds a Master’s degree in Biotechnology from the University of Hyderabad and is passionate about clinical studies. She enjoys reading study articles and literature reviews and is passionate about writing.
Use one of the following to cite this article in your essay, article, or report:
ap
Sai Lomte, Tarun. (2022, November 14). Test to Treat: Geographic disparities in to COVID-19 antivirals. Retrieved November 14, 2022, from https://www. news-medical. net/news/20221114/Test-to-Treat-geographic-disparities-in-COVID-19-antiviral-. aspx.
deputy
Sai Lomte, Tarun. ” Test to treat: geographic disparities in COVID-19 antivirals. “News-Medical. November 14, 2022.
Chicago
Sai Lomte, Tarun. ” Test to treat: geographic disparities in COVID-19 antivirals. “Medical news. https://www. news-medical. net/news/20221114/Test-to-Treat-geographic-disparities-in -COVID-19-antiviral-. aspx. (ED November 14, 2022).
Harvard
Sai Lomte, Tarun. 2022. Test to treat: geographic disparities in COVID-19 antivirals. News-Medical, ed November 14, 2022, https://www. news-medical. net/news/20221114/Test-to- Treat-Geographical-Disparities-in-COVID-19-Antiviral-. aspx.
News-Medical. net – An AZoNetwork website
Owned and operated through AZoNetwork, © 2000-2022